These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 26944732)
1. Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior. Notarangelo FM; Pocivavsek A Neuropharmacology; 2017 Jan; 112(Pt B):275-285. PubMed ID: 26944732 [TBL] [Abstract][Full Text] [Related]
2. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences. Fujigaki H; Yamamoto Y; Saito K Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951 [TBL] [Abstract][Full Text] [Related]
3. The kynurenine pathway in schizophrenia and bipolar disorder. Erhardt S; Schwieler L; Imbeault S; Engberg G Neuropharmacology; 2017 Jan; 112(Pt B):297-306. PubMed ID: 27245499 [TBL] [Abstract][Full Text] [Related]
4. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730 [TBL] [Abstract][Full Text] [Related]
5. Maternal Inflammation with Elevated Kynurenine Metabolites Is Related to the Risk of Abnormal Brain Development and Behavioral Changes in Autism Spectrum Disorder. Murakami Y; Imamura Y; Kasahara Y; Yoshida C; Momono Y; Fang K; Sakai D; Konishi Y; Nishiyama T Cells; 2023 Apr; 12(7):. PubMed ID: 37048160 [TBL] [Abstract][Full Text] [Related]
6. Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders. O'Farrell K; Harkin A Neuropharmacology; 2017 Jan; 112(Pt B):307-323. PubMed ID: 26690895 [TBL] [Abstract][Full Text] [Related]
7. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. Schwarcz R; Pellicciari R J Pharmacol Exp Ther; 2002 Oct; 303(1):1-10. PubMed ID: 12235226 [TBL] [Abstract][Full Text] [Related]
8. Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding. Pershing ML; Phenis D; Valentini V; Pocivavsek A; Lindquist DH; Schwarcz R; Bruno JP Psychopharmacology (Berl); 2016 Oct; 233(21-22):3725-3735. PubMed ID: 27527585 [TBL] [Abstract][Full Text] [Related]
9. A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats. Baratta AM; Viechweg SS; Mong JA; Pocivavsek A J Vis Exp; 2018 Aug; (138):. PubMed ID: 30176006 [TBL] [Abstract][Full Text] [Related]
10. Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia. Sathyasaikumar KV; Stachowski EK; Wonodi I; Roberts RC; Rassoulpour A; McMahon RP; Schwarcz R Schizophr Bull; 2011 Nov; 37(6):1147-56. PubMed ID: 21036897 [TBL] [Abstract][Full Text] [Related]
11. The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives. CiapaĆa K; Mika J; Rojewska E Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681715 [TBL] [Abstract][Full Text] [Related]
12. Prenatal Kynurenine Elevation Elicits Sex-Dependent Changes in Sleep and Arousal During Adulthood: Implications for Psychotic Disorders. Rentschler KM; Baratta AM; Ditty AL; Wagner NTJ; Wright CJ; Milosavljevic S; Mong JA; Pocivavsek A Schizophr Bull; 2021 Aug; 47(5):1320-1330. PubMed ID: 33823027 [TBL] [Abstract][Full Text] [Related]
13. Linking phencyclidine intoxication to the tryptophan-kynurenine pathway: Therapeutic implications for schizophrenia. Fujigaki H; Mouri A; Yamamoto Y; Nabeshima T; Saito K Neurochem Int; 2019 May; 125():1-6. PubMed ID: 30731185 [TBL] [Abstract][Full Text] [Related]
14. Prenatal Dynamics of Kynurenine Pathway Metabolism in Mice: Focus on Kynurenic Acid. Goeden N; Notarangelo FM; Pocivavsek A; Beggiato S; Bonnin A; Schwarcz R Dev Neurosci; 2017; 39(6):519-528. PubMed ID: 29080891 [TBL] [Abstract][Full Text] [Related]
15. Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia. Beggiato S; Notarangelo FM; Sathyasaikumar KV; Giorgini F; Schwarcz R J Psychopharmacol; 2018 Nov; 32(11):1223-1232. PubMed ID: 30354938 [TBL] [Abstract][Full Text] [Related]
17. Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders. Bai MY; Lovejoy DB; Guillemin GJ; Kozak R; Stone TW; Koola MM Complex Psychiatry; 2021 Aug; 7(1-2):19-33. PubMed ID: 35141700 [TBL] [Abstract][Full Text] [Related]
18. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Kennedy PJ; Cryan JF; Dinan TG; Clarke G Neuropharmacology; 2017 Jan; 112(Pt B):399-412. PubMed ID: 27392632 [TBL] [Abstract][Full Text] [Related]
19. Maternal immune activation in rats blunts brain cytokine and kynurenine pathway responses to a second immune challenge in early adulthood. Clark SM; Notarangelo FM; Li X; Chen S; Schwarcz R; Tonelli LH Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():286-294. PubMed ID: 30267854 [TBL] [Abstract][Full Text] [Related]
20. Possibility of Amino Acid Treatment to Prevent the Psychiatric Disorders via Modulation of the Production of Tryptophan Metabolite Kynurenic Acid. Fukuwatari T Nutrients; 2020 May; 12(5):. PubMed ID: 32414200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]